340 related articles for article (PubMed ID: 19330863)
1. Differential expression of lumican and fatty acid binding protein-1: new insights into the histologic spectrum of nonalcoholic fatty liver disease.
Charlton M; Viker K; Krishnan A; Sanderson S; Veldt B; Kaalsbeek AJ; Kendrick M; Thompson G; Que F; Swain J; Sarr M
Hepatology; 2009 Apr; 49(4):1375-84. PubMed ID: 19330863
[TBL] [Abstract][Full Text] [Related]
2. Lumican, an extracellular matrix proteoglycan, is a novel requisite for hepatic fibrosis.
Krishnan A; Li X; Kao WY; Viker K; Butters K; Masuoka H; Knudsen B; Gores G; Charlton M
Lab Invest; 2012 Dec; 92(12):1712-25. PubMed ID: 23007134
[TBL] [Abstract][Full Text] [Related]
3. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
Suppli MP; Rigbolt KTG; Veidal SS; Heebøll S; Eriksen PL; Demant M; Bagger JI; Nielsen JC; Oró D; Thrane SW; Lund A; Strandberg C; Kønig MJ; Vilsbøll T; Vrang N; Thomsen KL; Grønbæk H; Jelsing J; Hansen HH; Knop FK
Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G462-G472. PubMed ID: 30653341
[TBL] [Abstract][Full Text] [Related]
4. Enhanced A-FABP expression in visceral fat: potential contributor to the progression of NASH.
Yoon MY; Sung JM; Song CS; Lee WY; Rhee EJ; Shin JH; Yoo CH; Chae SW; Kim JY; Jin W; Cho YK
Clin Mol Hepatol; 2012 Sep; 18(3):279-86. PubMed ID: 23091808
[TBL] [Abstract][Full Text] [Related]
5. Nrf2 deletion causes "benign" simple steatosis to develop into nonalcoholic steatohepatitis in mice fed a high-fat diet.
Wang C; Cui Y; Li C; Zhang Y; Xu S; Li X; Li H; Zhang X
Lipids Health Dis; 2013 Nov; 12():165. PubMed ID: 24188280
[TBL] [Abstract][Full Text] [Related]
6. Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease.
Abrams GA; Kunde SS; Lazenby AJ; Clements RH
Hepatology; 2004 Aug; 40(2):475-83. PubMed ID: 15368453
[TBL] [Abstract][Full Text] [Related]
7. Identifying nonalcoholic fatty liver disease patients with active fibrosis by measuring extracellular matrix remodeling rates in tissue and blood.
Decaris ML; Li KW; Emson CL; Gatmaitan M; Liu S; Wang Y; Nyangau E; Colangelo M; Angel TE; Beysen C; Cui J; Hernandez C; Lazaro L; Brenner DA; Turner SM; Hellerstein MK; Loomba R
Hepatology; 2017 Jan; 65(1):78-88. PubMed ID: 27706836
[TBL] [Abstract][Full Text] [Related]
8. Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease.
Bell LN; Theodorakis JL; Vuppalanchi R; Saxena R; Bemis KG; Wang M; Chalasani N
Hepatology; 2010 Jan; 51(1):111-20. PubMed ID: 19885878
[TBL] [Abstract][Full Text] [Related]
9. Differential intrahepatic phospholipid zonation in simple steatosis and nonalcoholic steatohepatitis.
Wattacheril J; Seeley EH; Angel P; Chen H; Bowen BP; Lanciault C; Caprioli RM; Abumrad N; Flynn CR
PLoS One; 2013; 8(2):e57165. PubMed ID: 23451176
[TBL] [Abstract][Full Text] [Related]
10. Phosphatidylethanolamines Are Associated with Nonalcoholic Fatty Liver Disease (NAFLD) in Obese Adults and Induce Liver Cell Metabolic Perturbations and Hepatic Stellate Cell Activation.
Shama S; Jang H; Wang X; Zhang Y; Shahin NN; Motawi TK; Kim S; Gawrieh S; Liu W
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674549
[TBL] [Abstract][Full Text] [Related]
11. Plasma phospholipids and fatty acid composition differ between liver biopsy-proven nonalcoholic fatty liver disease and healthy subjects.
Ma DW; Arendt BM; Hillyer LM; Fung SK; McGilvray I; Guindi M; Allard JP
Nutr Diabetes; 2016 Jul; 6(7):e220. PubMed ID: 27428872
[TBL] [Abstract][Full Text] [Related]
12. Lipotoxicity and steatohepatitis in an overfed mouse model for non-alcoholic fatty liver disease.
Gaemers IC; Stallen JM; Kunne C; Wallner C; van Werven J; Nederveen A; Lamers WH
Biochim Biophys Acta; 2011 Apr; 1812(4):447-58. PubMed ID: 21216282
[TBL] [Abstract][Full Text] [Related]
13. Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease.
Charlton M; Angulo P; Chalasani N; Merriman R; Viker K; Charatcharoenwitthaya P; Sanderson S; Gawrieh S; Krishnan A; Lindor K
Hepatology; 2008 Feb; 47(2):484-92. PubMed ID: 18220286
[TBL] [Abstract][Full Text] [Related]
14. Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis.
Sreekumar R; Rosado B; Rasmussen D; Charlton M
Hepatology; 2003 Jul; 38(1):244-51. PubMed ID: 12830008
[TBL] [Abstract][Full Text] [Related]
15. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM
Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
[TBL] [Abstract][Full Text] [Related]
16. Expression of IGF-1 receptor and GH receptor in hepatic tissue of patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Osganian SA; Subudhi S; Masia R; Drescher HK; Bartsch LM; Chicote ML; Chung RT; Gee DW; Witkowski ER; Bredella MA; Lauer GM; Corey KE; Dichtel LE
Growth Horm IGF Res; 2022 Aug; 65():101482. PubMed ID: 35780715
[TBL] [Abstract][Full Text] [Related]
17. Histologic spectrum of nonalcoholic fatty liver disease in morbidly obese adolescents.
Xanthakos S; Miles L; Bucuvalas J; Daniels S; Garcia V; Inge T
Clin Gastroenterol Hepatol; 2006 Feb; 4(2):226-32. PubMed ID: 16469684
[TBL] [Abstract][Full Text] [Related]
18. The relationship between hepatic resistin overexpression and inflammation in patients with nonalcoholic steatohepatitis.
Shen C; Zhao CY; Wang W; Wang YD; Sun H; Cao W; Yu WY; Zhang L; Ji R; Li M; Gao J
BMC Gastroenterol; 2014 Feb; 14():39. PubMed ID: 24559185
[TBL] [Abstract][Full Text] [Related]
19. A lipidomic analysis of nonalcoholic fatty liver disease.
Puri P; Baillie RA; Wiest MM; Mirshahi F; Choudhury J; Cheung O; Sargeant C; Contos MJ; Sanyal AJ
Hepatology; 2007 Oct; 46(4):1081-90. PubMed ID: 17654743
[TBL] [Abstract][Full Text] [Related]
20. Hepatic Alanine Differentiates Nonalcoholic Steatohepatitis From Simple Steatosis in Humans and Mice: A Proton MR Spectroscopy Study With Long Echo Time.
Kim TH; Jun HY; Kim KJ; Lee YH; Lee MS; Choi KH; Yun KJ; Jeong YY; Jun CH; Cho EY; Yoon KH
J Magn Reson Imaging; 2017 Nov; 46(5):1298-1310. PubMed ID: 28225569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
